Clinical Trials - November 4, 2014
First patient enrolled in Isofol Medical trial
Isofol Medical has announced that the first patient has been enrolled in a Phase I/II, single centre, open label study to identify the safety and tolerability of a dose of Modufolin in combination with the routine doses of 5–FU and oxaliplatin. The study will be carried out in patients with stage IV colon cancer and […]
Collaboration - August 26, 2014
Recipharm collaborates with Isofol Medical
Recipharm forms a new collaboration with Isofol Medical to manufacture Isofol’s drug candidate Modufolin. Furthermore, the life science sector investor Recipharm Venture Fund has announced that it has invested SEK 8 million in Isofol Medical. Isofol Medical AB is currently evaluating its drug candidate Modufolin in two clinical phase I/II studies. Modufolin is an endogenous […]